Breast cancer survivors' risk of interval cancers and false positive results in organized mammography screening
- PMID: 32608178
- PMCID: PMC7433834
- DOI: 10.1002/cam4.3182
Breast cancer survivors' risk of interval cancers and false positive results in organized mammography screening
Abstract
Background: Breast cancer survivors are increasing followed for new breast cancers / recurrences by mammography screening only. We aimed at assessing how often breast cancer survivors get a false positive or false negative result at mammography screening.
Methods: All mammography screenings performed between 2007 and 2017 in the Danish national mammography screening programme were included. Screenings in women with a breast cancer diagnosis prior to invitation were included in the "breast cancer survivors" group, while remaining screenings were included in the "no previous breast cancer" group. We compared the proportion of false positive screenings and the proportion of breast cancers detected at screening among breast cancer survivors and women without previous breast cancer. The analyses were further stratified according to whether the women had a diagnostic breast imaging in the 21 months prior to the screening.
Results: At initial screenings, breast cancer survivors had a significant lower false positive risk than other women, while the risk was similar at subsequent screenings. Breast cancer survivors had a significant lower proportion of breast cancers detected at screening compared to other women. This was true both for women who had a diagnostic breast imaging in the 21 months prior to screening and those who did not.
Conclusion: This study shows that breast cancers survivors have a smaller amount of their new breast cancers detected at mammography screening, when compare to the amount of new breast cancers detected at mammography screening among women without previous breast cancer. The lower sensitivity does not seem to be due to different behavior among breast cancer survivors.
Keywords: cancer screening; cancer survivors; false negative reactions; false positive reactions; mammography.
© 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
All authors declare no potential conflicts of interest.
Similar articles
-
Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.APMIS Suppl. 1998;83:1-44. APMIS Suppl. 1998. PMID: 9850674
-
Supplemental MRI Screening for Women with Extremely Dense Breast Tissue.N Engl J Med. 2019 Nov 28;381(22):2091-2102. doi: 10.1056/NEJMoa1903986. N Engl J Med. 2019. PMID: 31774954 Clinical Trial.
-
Clinical and radiological features of breast tumors according to history of false-positive results in mammography screening.Cancer Epidemiol. 2013 Oct;37(5):660-5. doi: 10.1016/j.canep.2013.07.006. Epub 2013 Aug 17. Cancer Epidemiol. 2013. PMID: 23962702
-
Digital breast tomosynthesis (3D-mammography) screening: A pictorial review of screen-detected cancers and false recalls attributed to tomosynthesis in prospective screening trials.Breast. 2016 Apr;26:119-34. doi: 10.1016/j.breast.2016.01.007. Epub 2016 Feb 18. Breast. 2016. PMID: 27017251 Review.
-
Factors Influencing Surveillance Mammography Adherence Among Breast Cancer Survivors.Oncol Nurs Forum. 2019 Nov 1;46(6):701-714. doi: 10.1188/19.ONF.701-714. Oncol Nurs Forum. 2019. PMID: 31626613
Cited by
-
Choice of Assessment and Subsequent Risk of Breast Cancer among Women with False-Positive Mammography Screening.Cancers (Basel). 2023 Mar 20;15(6):1867. doi: 10.3390/cancers15061867. Cancers (Basel). 2023. PMID: 36980754 Free PMC article.
-
False negative breast cancers on imaging and associated risk factors: a single institution six-year analysis.Breast Cancer Res Treat. 2024 Jun;205(3):507-520. doi: 10.1007/s10549-024-07259-0. Epub 2024 Mar 14. Breast Cancer Res Treat. 2024. PMID: 38483757
-
Routine and interval detection of locoregional breast cancer recurrences and risk of subsequent distant metastasis.Breast Cancer Res Treat. 2023 Jan;197(1):123-135. doi: 10.1007/s10549-022-06757-3. Epub 2022 Oct 31. Breast Cancer Res Treat. 2023. PMID: 36315307 Free PMC article.
References
-
- Kurtz JM, Amalric R, Brandone H, et al. Local recurrence after breast conserving surgery and radiotherapy; frequency, time course, and prognosis. Cancer. 1989;63:1912‐1917. - PubMed
-
- Lin NU, Thomssen C, Cardoso F, et al. International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)‐MBC Task Force: Surveillance, staging, and evaluation of patients with early‐stage and metastatic breast cancer. Breast. 2013;22:203‐210. - PubMed
-
- Independent UK Panel on Breast Cancer Screening . The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380:1778‐1786. - PubMed
-
- Lauby‐Secretan B, Scoccianti C, Loomis D, et al. Breast‐cancer Screening — viewpoint of the IARC working group. N Engl J Med. 2015;372:2353‐2358. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical